We randomized 33 patients ( from the Penn State Hershey Eye Center ) with at least 1 eye with mild to moderate NPDR ( Early Treatment Diabetic Retinopathy Study level 20-43 ) to doxycycline monohydrate , 50 mg/d , or daily placebo for 24 months .